Provides marine natural products for drug discovery, a screening system for angiogenetic effectors, artificial media for cells and physiological characterization of recombinant enzymes and transgenic animals.
Identifies sentinel nucleic acid expression profiles for use in developing assays associated with the prevention, diagnosis, and treatment of a variety of chronic diseases and catastrophic illnesses. Includes company history, staff and a list of current research projects.
A publicly traded (TSX: PLI, OTCQX: PFSCF) biopharmaceutical company specializing in bioseparation, plasma-derived therapeutics and small-molecule drug development. Offers technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens.
Offers products for the health care, agriculture and industrial chemicals markets. Includes outline of expertise, and facilities for production, administration, research and development in four continents.